WRITE FOR US
September 17, 2018 | by Nqaba Matshazi
Vital Therapies’ Stock Plummets After Phase 3 Trial For Liver Disease Flops
Pharma
September 17, 2018
Vital Therapies’ Stock Plummets After Phase 3 Trial For Liver Disease Flops
Biotech company, Vital Therapies’ stock plunged by almost 89 percent after a Phase III trial of
View moreInvesting & Startups
September 17, 2018
Atreca’s $125M round brings new immunotherapy closer to clinical trials
Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep
View moreInvesting & Startups
September 13, 2018
OncoResponse Raised $40M for Unique Drug Candidates Clinical Studies
OncoResponse, a biotech startup formed with the University of Texas M.D. Anderson Cancer Center in
View moreIllinois Healthcare News
September 13, 2018
Controversy Over Funds for Emergency Pharmacy Benefits in Illinois
The Rauner administration is once again under fire. This time, three Illinois lawmakers seek
View morePharma
September 13, 2018
4D Molecular Therapeutics Raises $90M; Clinical Testing for Gene Therapies
Gene therapy firm, 4D Molecular Therapeutics (4DMT) is on the verge of taking its therapies for
View moreInvesting & Startups
September 12, 2018
Inscripta Acquires Solana As It Accelerates Commercialization Drive
Genome editing company, Inscripta has announced the acquisition of life sciences firm, Solana
View moreBiotech
September 10, 2018
Pfizer puts a stop on its clinical studies for a potential DMD drug
Patients suffering from Duchenne muscular dystrophy (DMD) and their families received
View morePharma
September 08, 2018
Researchers On The Verge Of Universal Vaccine Breakthrough
Researchers from the University of Pennsylvania believe they are on the verge of taking a
View morePharma
September 07, 2018
RootPath Raises $7 Million Seed Funding For Cancer Immunotherapy Programs
A Cambridge Massachusetts based immuno-oncology startup, RootPath, has raised $7 million in a seed
View moreDigital Disruption
September 07, 2018
Team at MIT Develops Wireless Systems to Track Tumors and Dispense Drugs
MIT scientists have developed a system capable of locating ingestible implants inside the body
View morePharma
September 05, 2018
Humana sues generic drug manufacturers for price fixing
Health insurance giant, Humana, is suing dozens of pharmaceutical companies it accuses of price
View morePharma
September 04, 2018
The Hottest Healthtech Startups Featured At Y Combinator’s Demo Day
For tech entrepreneurs looking for their big break, the Y Combinator’s biannual Demo Days is one
View moreBiotech
September 01, 2018
Arvinas goes public to bring its PROTAC-based anticancer drug to the market looking at an $100 mn IPO
On August 30th Arvinas, a preclinical biotech that is developing protein therapies for metastatic
View moreInvesting & Startups
August 31, 2018
$93 Million for TraceLink to Further Global Development to Fight Counterfeit Drugs
TraceLink Inc. announced August, 21 that it has closed a $93 million investment round led by
View morePartner Network
August 27, 2018
Natural Food and Supplement Guru Spots Hot Products and Companies
By Dan Shomon America has come a long way since the consensus piece of nutritional advice was,
View moreHealthcare Innovation
August 27, 2018
Scientists Develop Model To Predict Enterovirus Outbreaks 2 Years In Advance
Researchers at the United Kingdom’s Imperial College London have developed a mathematical model
View moreBiotech
August 24, 2018
UK Biotech Company Raises $84 Million for Novel Cancer Therapies
A United Kingdom based biotechnology company focusing on novel cancer therapies has secured $84
View moreBiotech
August 23, 2018
Healthcare Trends: Principia BioPharma Goes Public to Raise Money for New Drug
The clinical-stage biopharmaceutical firm Principia Biopharma, which researches and develops
View moreNews
August 23, 2018
The FDA Approved the First Direct Generic Competitor to the EpiPen
EpiPen, the biggest name-brand injector drug used to treat patients with life-threatening allergic
View moreBiotech
August 21, 2018
Entasis Therapeutics Might Help Patients Battling Drug Resistant Bacteria as Early as Next Year
Privately owned Entasis Therapeutics, a company working on new antibacterial drugs to treat
View morePharma
August 21, 2018
$150 Million in Series C Funding To Drive Orchard Therapeutics Commercialization
United Kingdom-based biotech firm, Orchard Therapeutics has closed a successful Series C financing
View morePharma
August 17, 2018
Startup Akouos Raises Millions for Sensorineural Hearing Loss Treatment
After raising $50 million from new investors, Boston based startup, Akouos, is set to begin
View morePharma
August 17, 2018
Therachon Gets $60 Million for Rare Genetic Disease Treatment
Swiss-based biotech company, Therachon, which focuses on developing rare genetic disease
View morePharma
August 16, 2018
Ambys Gets $140 Million Series A Funding to Cure Liver Disease
A new biotechnology company, Ambys Medicines, which is developing regenerative medicines for liver
View morePharma
August 13, 2018
Bright Prospects for Regenerative Medicine Industry, as Samumed Raises $438 Million
Drugmaker Samumed last week announced that it had closed its A-6 round of equity issuance with
View moreInvesting & Startups
August 10, 2018
See Which 10 Healthcare Startups Secured Over $1.7 Billion in Funding
It’s no surprise that healthcare startups are synonymous with future of the industry. The
View morePharma
August 08, 2018
SQZ Biotech Raises $72 Million to Develop New Cell Therapy Treatments
A Series C funding round by SQZ Biotech – a cell therapy firm developing new treatments
View moreIllinois Healthcare News
August 06, 2018
Injection Drug Use Endemic Spawns Increase in Illinois Hepatitis C Cases
The Illinois Department of Public Health (IDPH) has announced that the prevalence of hepatitis C
View morePharma
August 01, 2018
Alector Receives $133 Million Towards Developing Treatments for Alzheimer’s
On Wednesday, Alector, a startup that focuses on developing new treatments for Alzheimer’s
View morePharma
July 31, 2018
Artificial Intelligence Startup Healx Gets $10 Million to Find Cures for Rare Diseases
On July 26th, Healx, a four-year-old Cambridge (UK) technology company that develops innovative
View morePharma
July 31, 2018
Secretive Biotech Startup Gossamer Bio Bags $230 Million in Series B Funding
Gossamer Bio raised $230 million in a Series B financing round – following a $100 million
View morePharma
July 30, 2018
Great News for Big Pharma: BenevolentAI Uses New Funds to Prepare ALS Drug Clinical Trials
This spring, an investor-backed British artificial intelligence start-up, BenevolentAI, received
View moreDigital Disruption
July 23, 2018
Saving Patients & Hospitals Millions with Government Programs
Healthcare Weekly recently interviewed Doc&I CEO, Brad Becker. Brad has vast operational
View moreInvesting & Startups
July 20, 2018
Verge Genomics Wants to Use Artificial Intelligence to Cure Diseases (and Gets $32M in Funding to Get There)
Drug discovery is a long and tedious enterprise. According to Tufts Center for the Study of Drug
View moreInnovation
July 20, 2018
3 Exciting Advances in Biotechnology
Biotechnology has profoundly changed the way people are being diagnosed and treated. Medical trail
View moreInnovation
July 12, 2018
5 Innovations That Will Change the Treatment of Heart Disease
The functions of the human heart continue to challenge physicians worldwide. A quick glance at
View more
